Back
Monopar Therapeutics Stock Predictions
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Buy
65
MNPR
Monopar Therapeutics
Last Price:
21.71
Seasonality Move:
7.43%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.Monopar Therapeutics Stock Forecast
- Over the next 52 weeks, Monopar Therapeutics has on average historically fallen by 2.6% based on the past 4 years of stock performance.
- Monopar Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Monopar Therapeutics Stock Undervalued?
The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal. - MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Monopar Therapeutics has on average historically fallen by 2.6% based on the past 4 years of stock performance.
Monopar Therapeutics Stock Rating
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics overpriced?
- Monopar Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
38.50
52-Week Low:
1.37
Prediction Charts
Market Cap:
114.98M
Price in USD:
32.66
Volume:
19.05M
Beta:
1.28
Technical Analysis
SMA50:
4.51
SMA100:
4.05
SMA200:
3.61
52-Wk Change:
1299.91%
Stock Predictions
-
Is Monopar Therapeutics stock public?
Yes, Monopar Therapeutics is a publicly traded company. -
What is the Monopar Therapeutics stock quote today?
The Monopar Therapeutics stock price is 32.66 USD today. -
How to buy Monopar Therapeutics stock online?
You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-4 | 4.55 | 4.61 | 4.76 | 4.52 |
| Oct-7 | 4.52 | 5.08 | 5.30 | 4.52 |
| Oct-8 | 5.19 | 5.34 | 5.66 | 5.09 |
| Oct-9 | 5.28 | 5.08 | 5.52 | 4.86 |
| Oct-10 | 4.95 | 5.17 | 5.23 | 4.81 |
| Oct-11 | 5.56 | 5.50 | 5.73 | 5.03 |
| Oct-14 | 5.37 | 5.39 | 5.59 | 5.32 |
| Oct-15 | 5.41 | 5.15 | 5.41 | 5.06 |
| Oct-16 | 5.19 | 5.26 | 5.30 | 5.16 |
| Oct-18 | 5.84 | 5.50 | 5.84 | 5.46 |
| Oct-21 | 5.44 | 5.25 | 5.66 | 5.08 |
| Oct-22 | 5.50 | 5.25 | 5.50 | 5.15 |
| Oct-23 | 5.10 | 4.63 | 5.30 | 4.50 |
| Oct-24 | 5.12 | 32.66 | 38.50 | 4.87 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.